JP2016523561A5 - - Google Patents

Download PDF

Info

Publication number
JP2016523561A5
JP2016523561A5 JP2016525449A JP2016525449A JP2016523561A5 JP 2016523561 A5 JP2016523561 A5 JP 2016523561A5 JP 2016525449 A JP2016525449 A JP 2016525449A JP 2016525449 A JP2016525449 A JP 2016525449A JP 2016523561 A5 JP2016523561 A5 JP 2016523561A5
Authority
JP
Japan
Prior art keywords
vertebrate
mrap2
cell according
modification
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016525449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016523561A (ja
JP6443811B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/045934 external-priority patent/WO2015006437A1/en
Publication of JP2016523561A publication Critical patent/JP2016523561A/ja
Publication of JP2016523561A5 publication Critical patent/JP2016523561A5/ja
Application granted granted Critical
Publication of JP6443811B2 publication Critical patent/JP6443811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016525449A 2013-07-10 2014-07-09 Mrap2ノックアウト Active JP6443811B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361844666P 2013-07-10 2013-07-10
US61/844,666 2013-07-10
PCT/US2014/045934 WO2015006437A1 (en) 2013-07-10 2014-07-09 Mrap2 knockouts

Publications (3)

Publication Number Publication Date
JP2016523561A JP2016523561A (ja) 2016-08-12
JP2016523561A5 true JP2016523561A5 (enExample) 2017-08-10
JP6443811B2 JP6443811B2 (ja) 2018-12-26

Family

ID=52280563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016525449A Active JP6443811B2 (ja) 2013-07-10 2014-07-09 Mrap2ノックアウト

Country Status (8)

Country Link
US (2) US20160143256A1 (enExample)
EP (1) EP3019005B1 (enExample)
JP (1) JP6443811B2 (enExample)
KR (1) KR102297747B1 (enExample)
CN (1) CN105555132B (enExample)
AU (1) AU2014287250A1 (enExample)
CA (1) CA2917961A1 (enExample)
WO (1) WO2015006437A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
CN107250148B (zh) 2014-12-03 2021-04-16 安捷伦科技有限公司 具有化学修饰的指导rna
ES2884838T3 (es) 2015-04-06 2021-12-13 Univ Leland Stanford Junior ARN guía químicamente modificados para la regulación génica mediada por CRISPR/CAS
US12043852B2 (en) 2015-10-23 2024-07-23 President And Fellows Of Harvard College Evolved Cas9 proteins for gene editing
RU2733841C2 (ru) * 2016-03-28 2020-10-07 Торэй Индастриз, Инк. Иммуноиндуцирующее средство
US20190112370A1 (en) * 2016-03-28 2019-04-18 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancers
KR101863653B1 (ko) * 2016-06-02 2018-06-05 전남대학교 산학협력단 락토페린 발현용 넉-인 벡터 및 이를 이용한 넉인 방법
US10767175B2 (en) 2016-06-08 2020-09-08 Agilent Technologies, Inc. High specificity genome editing using chemically modified guide RNAs
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
CN109804066A (zh) 2016-08-09 2019-05-24 哈佛大学的校长及成员们 可编程cas9-重组酶融合蛋白及其用途
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
AU2017342543B2 (en) 2016-10-14 2024-06-27 President And Fellows Of Harvard College AAV delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
EP3724214A4 (en) 2017-12-15 2021-09-01 The Broad Institute Inc. SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
DE112020001306T5 (de) 2019-03-19 2022-01-27 Massachusetts Institute Of Technology Verfahren und zusammensetzungen zur editierung von nukleotidsequenzen
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
JP2023525304A (ja) 2020-05-08 2023-06-15 ザ ブロード インスティテュート,インコーポレーテッド 標的二本鎖ヌクレオチド配列の両鎖同時編集のための方法および組成物
CN115232812B (zh) * 2021-07-12 2025-10-24 南京启真基因工程有限公司 一种构建mrap2基因突变的重症早发性肥胖症模型猪核移植供体细胞的方法
US11884915B2 (en) 2021-09-10 2024-01-30 Agilent Technologies, Inc. Guide RNAs with chemical modification for prime editing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US6060642A (en) * 1997-08-15 2000-05-09 The Regents Of The University Of California Serotonin 5-HT6 receptor knockout mouse
EP1353549A2 (en) * 2000-06-01 2003-10-22 PHARMACIA & UPJOHN COMPANY Mice heterozygous for wfs1 gene as mouse models for depression
WO2005108415A2 (en) * 2004-04-30 2005-11-17 Biogen Idec Ma Inc. Membrane associated molecules
ES2626025T3 (es) 2005-10-18 2017-07-21 Precision Biosciences Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
US20100120627A1 (en) * 2006-08-02 2010-05-13 Abdelmajid Belouchi Genemap of the human genes associated with psoriasis
CA3186126A1 (en) * 2011-09-21 2013-03-28 Sangamo Biosciences, Inc. Methods and compositions for regulation of transgene expression

Similar Documents

Publication Publication Date Title
JP2016523561A5 (enExample)
Zhang et al. Polymorphisms of myostatin gene (MSTN) in four goat breeds and their effects on Boer goat growth performance
JP2015533284A5 (enExample)
Mu et al. Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development
JP2015523863A5 (enExample)
Houbrechts et al. Permanent deiodinase type 2 deficiency strongly perturbs zebrafish development, growth, and fertility
US20190281798A1 (en) Genetically Modified Non-Human Animal With Human Or Chimeric PD-L1
JP2019216750A (ja) ヒト化il−15動物
RU2014148107A (ru) Грызуны с гуманизированным il-7
PH12015501797A1 (en) Hornless livestock
JP6505689B2 (ja) ヒト化b細胞活性化因子遺伝子を有する非ヒト動物
RU2015120467A (ru) Контроль полового созревания у животных
RU2016123135A (ru) Отличные от человека животные, содержащие гуманизированный ген индуцирующего пролиферацию лиганда
HRP20231121T1 (hr) Životinje koje nisu ljudi, koje imaju gen za humanizirani protein koji regulira signale
JP2015519923A5 (enExample)
IL319209A (en) Non-human animals containing a humanized ASGR1 locus
US20190223416A1 (en) Canine genome editing
JP5868403B2 (ja) 体重調節作用を有する物質をスクリーニングするための方法
Amills The application of genomic technologies to investigate the inheritance of economically important traits in goats
Moon et al. Generation of mice with a conditional and reporter allele for Tmem100
Tian et al. Single-nucleotide polymorphism analysis of GH, GHR, and IGF-1 genes in minipigs
Devlin et al. Growth and endocrine effect of growth hormone transgene dosage in diploid and triploid coho salmon
Chang et al. Association of prolactin haplotypes with reproductive traits in Tsaiya ducks
Hauschild-Quintern et al. Gender non-specific efficacy of ZFN mediated gene targeting in pigs
DE112016001619T5 (de) Verfahren zum herstellen eines nicht-humanen säugetiers oder fisches, das/der jeweils in der lage ist, gameten herzustellen, die ihren ursprung in einem anderen individuum haben